BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 23246854)

  • 1. Transurethral resection versus intermittent catheterization in patients with retention after combined brachytherapy/external beam radiotherapy for prostate cancer: transurethral resection.
    Stone NN
    J Urol; 2013 Mar; 189(3):800-1. PubMed ID: 23246854
    [No Abstract]   [Full Text] [Related]  

  • 2. Transurethral resection versus intermittent catheterization in patients with retention after combined brachytherapy/external beam radiotherapy for prostate cancer: intermittent catheterization.
    Boone TB
    J Urol; 2013 Mar; 189(3):801-2. PubMed ID: 23246852
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of continence following 532 nm laser prostatectomy for patients previously treated with radiation therapy or brachytherapy.
    No D; Osterberg EC; Otto B; Naftali I; Choi B
    Lasers Surg Med; 2013 Aug; 45(6):358-61. PubMed ID: 23813669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary and rectal complications of contemporary permanent transperineal brachytherapy for prostate carcinoma with or without external beam radiation therapy.
    Sarosdy MF
    Cancer; 2004 Aug; 101(4):754-60. PubMed ID: 15305406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preimplant predictive factors of urinary retention after iodine 125 prostate brachytherapy.
    Mabjeesh NJ; Chen J; Stenger A; Matzkin H
    Urology; 2007 Sep; 70(3):548-53. PubMed ID: 17905113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severity categories of the International Prostate Symptom Score before, and urinary morbidity after, permanent prostate brachytherapy.
    Gutman S; Merrick GS; Butler WM; Wallner KE; Allen Z; Galbreath RW; Adamovich E
    BJU Int; 2006 Jan; 97(1):62-8. PubMed ID: 16336330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Summary of simultaneous irradiation for prostate cancer.
    Critz FA
    Urology; 2004 Oct; 64(4):633-6. PubMed ID: 15491686
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of hormonal manipulation on urinary function following permanent prostate brachytherapy.
    Merrick GS; Butler WM; Wallner KE; Murray B; Allen Z; Lief JH; Galbreath RW
    Brachytherapy; 2004; 3(1):22-9. PubMed ID: 15110310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One-step customized transurethral resection of the prostate and permanent implant brachytherapy for selected prostate cancer patients: technically feasible but too toxic.
    Cosset JM; Barret E; Castro-Pena P; Cathelineau X; Galiano M; Rozet F; Pierrat N; Timbert M; Vallancien G
    Brachytherapy; 2011; 10(1):29-34. PubMed ID: 21251622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary morbidity and incontinence following transurethral resection of the prostate after brachytherapy.
    Kollmeier MA; Stock RG; Cesaretti J; Stone NN
    J Urol; 2005 Mar; 173(3):808-12. PubMed ID: 15711274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low morbidity following high dose rate brachytherapy in the setting of prior transurethral prostate resection.
    Peddada AV; Jennings SB; Faricy PO; Walsh RA; White GA; Monroe AT
    J Urol; 2007 Nov; 178(5):1963-7. PubMed ID: 17868718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re: Late urinary morbidity with high dose prostate brachytherapy as a boost to conventional external beam radiation therapy for local and locally advanced prostate cancer.
    Deger S
    J Urol; 2004 Sep; 172(3):1198; author reply 1198. PubMed ID: 15311075
    [No Abstract]   [Full Text] [Related]  

  • 13. Early channel transurethral resection of the prostate for patients with urinary retention after brachytherapy.
    Zhang YY; Zhang ZG; Yu YL; Chen YC; Ni KX; Wang MC; Zhao WP; Rehman F; Wan SP; Li GH
    J Zhejiang Univ Sci B; 2014 Aug; 15(8):756-60. PubMed ID: 25091995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Previous transurethral resection of the prostate is not a contraindication to high-dose rate brachytherapy for prostate cancer.
    Luo HL; Fang FM; Chuang YC; Chiang PH
    BJU Int; 2009 Dec; 104(11):1620-3. PubMed ID: 19624535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with the frequency of self-intermittent catheterization after prostate brachytherapy.
    Schwartz DJ; Schild SE; Wong WW; Vora SA
    Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):60-3. PubMed ID: 15629594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary fistulas following external radiation or permanent brachytherapy for the treatment of prostate cancer.
    Chrouser KL; Leibovich BC; Sweat SD; Larson DW; Davis BJ; Tran NV; Zincke H; Blute ML
    J Urol; 2005 Jun; 173(6):1953-7. PubMed ID: 15879789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Usefulness of urethral endoprosthesis in the management of urinary retention after brachytherapy for localized prostate cancer].
    Kerkeni W; Chahwan C; Lenormand C; Dubray B; Benyoucef A; Pfister C
    Prog Urol; 2014 Mar; 24(3):164-6. PubMed ID: 24560204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seed implant retention score predicts the risk of prolonged urinary retention after prostate brachytherapy.
    Lee HK; Adams MT; Shi Q; Basillote J; Lamonica J; Miranda L; Motta J
    Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1445-9. PubMed ID: 19553032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic dose-feedback prostate brachytherapy in patients with large prostates and/or planned transurethral surgery before implantation.
    Acher PL; Popert R; Morris SL; Potters L; Austin-Smith SL; Johnson UH; Nichol JE; Beaney RP
    BJU Int; 2007 May; 99(5):1066-71. PubMed ID: 17233801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Transurethral resection of the prostate for urinary retention after seed implantation for prostate cancer: report of 2 cases].
    Yang WZ; Guo JY; Li Y; An F; Zhang YQ; Ma T
    Zhonghua Nan Ke Xue; 2011 Nov; 17(11):1011-3. PubMed ID: 22141273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.